| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
294,170 |
229,314 |
$16.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
63,600 |
58,700 |
$8.62M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,894 |
22,067 |
$5.73M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
46,422 |
43,106 |
$4.58M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
113,344 |
107,400 |
$4.02M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
74,562 |
70,525 |
$1.87M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,170 |
15,592 |
$1.70M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
6,735 |
6,430 |
$1.53M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
7,433 |
6,467 |
$1.37M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,462 |
7,852 |
$1.03M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,733 |
14,832 |
$983K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
10,277 |
9,973 |
$918K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,788 |
6,212 |
$733K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,362 |
1,285 |
$667K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,869 |
1,746 |
$666K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18,881 |
17,965 |
$592K |
| 71046 |
Radiologic examination, chest; 2 views |
17,755 |
16,220 |
$577K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
29,219 |
11,689 |
$561K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,186 |
6,526 |
$550K |
| 90834 |
Psychotherapy, 45 minutes with patient |
8,043 |
4,644 |
$545K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,241 |
2,308 |
$523K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,097 |
8,717 |
$501K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,218 |
11,377 |
$452K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,060 |
4,076 |
$452K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
965 |
603 |
$448K |
| A0425 |
Ground mileage, per statute mile |
14,811 |
10,967 |
$442K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,166 |
7,739 |
$425K |
| 59025 |
Fetal non-stress test |
3,406 |
2,268 |
$424K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
16,858 |
7,420 |
$404K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,214 |
6,915 |
$403K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
6,308 |
5,857 |
$343K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,163 |
3,868 |
$340K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
2,066 |
1,861 |
$322K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
5,925 |
5,508 |
$317K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
4,542 |
3,648 |
$311K |
| 90832 |
Psychotherapy, 30 minutes with patient |
4,634 |
2,782 |
$305K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,707 |
1,555 |
$295K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,999 |
4,759 |
$292K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
10,082 |
8,021 |
$276K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,987 |
2,810 |
$275K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,298 |
1,228 |
$275K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,856 |
4,535 |
$273K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,530 |
8,987 |
$271K |
| 77386 |
|
1,120 |
87 |
$250K |
| Q3014 |
Telehealth originating site facility fee |
16,567 |
14,096 |
$241K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,396 |
4,320 |
$240K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,810 |
4,730 |
$240K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,550 |
12,817 |
$236K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
3,198 |
1,441 |
$231K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,210 |
2,096 |
$224K |
| 93975 |
|
1,467 |
1,392 |
$219K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
656 |
586 |
$217K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,518 |
3,390 |
$217K |
| 52000 |
|
1,276 |
1,226 |
$205K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,655 |
1,591 |
$201K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,070 |
2,024 |
$200K |
| 97161 |
|
6,125 |
5,808 |
$198K |
| 99233 |
Prolong inpt eval add15 m |
5,995 |
3,398 |
$198K |
| 99215 |
Prolong outpt/office vis |
3,916 |
3,763 |
$191K |
| 77412 |
|
2,203 |
222 |
$182K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,842 |
2,735 |
$177K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
4,769 |
4,455 |
$171K |
| 94060 |
|
2,451 |
2,354 |
$170K |
| 84443 |
Thyroid stimulating hormone (TSH) |
27,361 |
25,914 |
$168K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,116 |
1,979 |
$162K |
| 80061 |
Lipid panel |
23,903 |
22,984 |
$161K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
39,358 |
33,990 |
$157K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
78 |
70 |
$156K |
| 76830 |
Ultrasound, transvaginal |
2,314 |
2,237 |
$156K |
| 20610 |
|
3,892 |
3,159 |
$153K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,300 |
2,220 |
$153K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,224 |
4,750 |
$151K |
| 90791 |
Psychiatric diagnostic evaluation |
1,793 |
1,737 |
$147K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
180 |
173 |
$146K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,479 |
4,299 |
$146K |
| 80053 |
Comprehensive metabolic panel |
80,571 |
68,119 |
$145K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,681 |
5,292 |
$138K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
486 |
467 |
$135K |
| 77336 |
|
2,806 |
1,172 |
$134K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,904 |
9,479 |
$133K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
9,518 |
9,008 |
$129K |
| 76801 |
|
1,897 |
1,802 |
$129K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
9,517 |
9,007 |
$128K |
| 90461 |
|
5,561 |
5,209 |
$127K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
703 |
419 |
$124K |
| 72141 |
|
993 |
966 |
$123K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,393 |
3,285 |
$122K |
| 43235 |
|
365 |
339 |
$118K |
| 71045 |
Radiologic examination, chest; single view |
3,964 |
3,438 |
$105K |
| 95811 |
|
407 |
393 |
$104K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,605 |
4,795 |
$99K |
| 93971 |
|
2,110 |
2,011 |
$99K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
4,189 |
3,490 |
$96K |
| 97803 |
|
3,540 |
3,017 |
$90K |
| 99223 |
Prolong inpt eval add15 m |
1,533 |
1,458 |
$89K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
4,025 |
3,960 |
$89K |
| 99336 |
|
2,639 |
2,267 |
$87K |
| 90686 |
|
12,209 |
11,963 |
$83K |
| 71250 |
|
2,186 |
2,122 |
$82K |
| 96367 |
|
2,390 |
1,499 |
$80K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28,733 |
27,326 |
$79K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,048 |
1,791 |
$79K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
552 |
524 |
$79K |
| 31575 |
|
1,236 |
1,121 |
$79K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
73,285 |
59,143 |
$78K |
| 72100 |
|
3,219 |
2,983 |
$76K |
| 70496 |
|
822 |
764 |
$76K |
| 76642 |
|
1,860 |
1,675 |
$74K |
| 80055 |
|
2,148 |
2,041 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
85,528 |
75,004 |
$72K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,385 |
1,312 |
$69K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,373 |
1,573 |
$67K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
289 |
270 |
$63K |
| 92557 |
|
1,396 |
1,339 |
$61K |
| 92587 |
|
567 |
564 |
$60K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,411 |
1,938 |
$55K |
| 93017 |
|
1,380 |
1,278 |
$54K |
| 31237 |
|
56 |
27 |
$52K |
| 00731 |
|
1,663 |
1,606 |
$52K |
| 98928 |
|
5,584 |
5,037 |
$51K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,270 |
1,236 |
$51K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,662 |
6,382 |
$50K |
| 77334 |
|
195 |
146 |
$50K |
| 77427 |
|
782 |
376 |
$50K |
| 82728 |
|
9,007 |
8,517 |
$48K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,389 |
3,268 |
$47K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
5,755 |
5,339 |
$46K |
| 85027 |
|
26,831 |
23,991 |
$46K |
| 93880 |
|
707 |
687 |
$45K |
| 81511 |
|
496 |
471 |
$45K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
35,777 |
30,226 |
$45K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,836 |
1,497 |
$44K |
| 88142 |
|
5,273 |
4,940 |
$44K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,930 |
1,712 |
$42K |
| A0434 |
Specialty care transport (sct) |
104 |
102 |
$42K |
| 77066 |
Tomosynthesis, mammo |
581 |
567 |
$41K |
| 43249 |
|
92 |
79 |
$40K |
| 77300 |
|
194 |
171 |
$39K |
| 29581 |
|
596 |
237 |
$38K |
| 90677 |
|
1,052 |
1,031 |
$38K |
| 70486 |
|
902 |
867 |
$38K |
| 97165 |
|
1,934 |
1,773 |
$38K |
| 82607 |
|
7,400 |
7,059 |
$38K |
| 86480 |
|
1,229 |
1,178 |
$38K |
| 71271 |
|
694 |
690 |
$36K |
| 74018 |
|
1,507 |
1,360 |
$36K |
| 99349 |
|
1,006 |
833 |
$36K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,646 |
3,476 |
$36K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12,800 |
6,470 |
$36K |
| 86803 |
|
5,662 |
5,374 |
$35K |
| 97802 |
|
721 |
650 |
$35K |
| 10060 |
|
320 |
308 |
$34K |
| 76536 |
|
612 |
604 |
$34K |
| 64450 |
|
76 |
66 |
$33K |
| 72050 |
|
863 |
829 |
$33K |
| 87510 |
|
7,077 |
6,573 |
$33K |
| 0001A |
|
2,041 |
2,020 |
$33K |
| 87660 |
|
7,076 |
6,572 |
$33K |
| 93970 |
|
353 |
339 |
$33K |
| 87088 |
|
16,707 |
15,134 |
$33K |
| 87480 |
|
7,079 |
6,575 |
$33K |
| 96127 |
|
1,912 |
1,801 |
$33K |
| 0002A |
|
1,911 |
1,891 |
$33K |
| 73630 |
|
4,485 |
3,877 |
$33K |
| 86900 |
|
3,640 |
3,290 |
$31K |
| 99205 |
Prolong outpt/office vis |
368 |
362 |
$31K |
| 99406 |
|
2,305 |
2,118 |
$30K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,644 |
2,465 |
$30K |
| 36561 |
|
38 |
38 |
$29K |
| 83655 |
|
2,995 |
2,836 |
$29K |
| 36569 |
|
117 |
106 |
$29K |
| 96415 |
|
793 |
544 |
$29K |
| 74183 |
|
174 |
161 |
$29K |
| 93922 |
|
1,554 |
1,478 |
$28K |
| 73030 |
|
3,481 |
3,003 |
$28K |
| 73502 |
|
2,736 |
2,451 |
$26K |
| 82746 |
|
4,732 |
4,504 |
$25K |
| 95806 |
|
448 |
438 |
$24K |
| 31231 |
|
296 |
255 |
$23K |
| 93923 |
|
644 |
625 |
$23K |
| 97162 |
|
842 |
796 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,885 |
1,789 |
$22K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
89 |
71 |
$22K |
| 83970 |
|
1,417 |
1,342 |
$22K |
| 73562 |
|
3,477 |
3,031 |
$21K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
313 |
311 |
$21K |
| J0897 |
Injection, denosumab, 1 mg |
41 |
38 |
$21K |
| 86703 |
|
3,133 |
2,979 |
$21K |
| 95886 |
|
2,102 |
1,515 |
$21K |
| 84439 |
|
6,290 |
5,917 |
$21K |
| 73610 |
|
3,140 |
2,735 |
$20K |
| 84702 |
|
3,383 |
2,591 |
$20K |
| 69210 |
|
2,070 |
1,945 |
$20K |
| 94010 |
|
2,524 |
2,436 |
$20K |
| 99443 |
|
838 |
807 |
$20K |
| 73130 |
|
2,777 |
2,228 |
$20K |
| 77065 |
Tomosynthesis, mammo |
412 |
369 |
$20K |
| 83550 |
|
5,891 |
5,580 |
$19K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16,172 |
10,948 |
$19K |
| 58301 |
|
123 |
104 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,316 |
2,201 |
$18K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
26 |
25 |
$18K |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
2,408 |
2,287 |
$18K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
794 |
774 |
$17K |
| 83540 |
|
6,772 |
6,419 |
$17K |
| 0004A |
|
832 |
821 |
$17K |
| 77080 |
|
585 |
582 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,796 |
8,897 |
$17K |
| 77014 |
|
1,092 |
122 |
$17K |
| 90651 |
|
1,466 |
1,331 |
$17K |
| 70491 |
|
172 |
161 |
$16K |
| J1453 |
Injection, fosaprepitant, 1 mg |
269 |
167 |
$16K |
| 87522 |
Neg quan hep c or qual rna |
745 |
710 |
$16K |
| 72110 |
|
897 |
825 |
$16K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
189 |
120 |
$15K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,651 |
1,192 |
$15K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
32 |
32 |
$15K |
| 73560 |
|
1,177 |
855 |
$15K |
| 73110 |
|
2,278 |
1,956 |
$15K |
| 73221 |
|
125 |
120 |
$15K |
| 90732 |
|
273 |
261 |
$14K |
| 58300 |
|
363 |
322 |
$14K |
| 90670 |
|
4,454 |
4,200 |
$14K |
| 87340 |
|
3,230 |
3,064 |
$14K |
| 99222 |
Initial hospital care, per day, moderate complexity |
289 |
279 |
$14K |
| 83735 |
|
14,038 |
11,138 |
$14K |
| 99188 |
|
1,272 |
1,220 |
$14K |
| 92567 |
|
3,236 |
3,112 |
$13K |
| 95816 |
|
225 |
209 |
$13K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
51 |
50 |
$13K |
| 83516 |
|
1,900 |
1,754 |
$13K |
| 64615 |
|
108 |
106 |
$13K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
41 |
41 |
$13K |
| 49083 |
|
29 |
13 |
$12K |
| 86140 |
|
8,581 |
7,522 |
$12K |
| 82565 |
|
13,723 |
11,574 |
$12K |
| 17110 |
|
268 |
229 |
$12K |
| 72070 |
|
400 |
377 |
$12K |
| 86003 |
|
294 |
264 |
$12K |
| 82105 |
|
1,335 |
1,266 |
$11K |
| 93296 |
|
1,429 |
1,307 |
$11K |
| 84481 |
|
1,798 |
1,705 |
$11K |
| 82947 |
|
6,544 |
5,748 |
$11K |
| 86704 |
|
2,322 |
2,218 |
$11K |
| 76775 |
|
373 |
366 |
$11K |
| 99442 |
|
633 |
613 |
$11K |
| 85610 |
|
20,363 |
13,318 |
$10K |
| 87081 |
|
4,962 |
4,753 |
$10K |
| 80069 |
|
4,722 |
3,950 |
$10K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
157 |
123 |
$10K |
| 86038 |
|
1,872 |
1,781 |
$10K |
| 74221 |
|
131 |
131 |
$10K |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
727 |
706 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
89 |
66 |
$9K |
| 96158 |
|
211 |
199 |
$9K |
| 90473 |
|
205 |
199 |
$9K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
407 |
394 |
$9K |
| 82950 |
|
2,233 |
2,144 |
$9K |
| 86592 |
|
2,916 |
2,770 |
$9K |
| 36591 |
|
768 |
507 |
$9K |
| 87186 |
|
5,856 |
5,356 |
$9K |
| 96417 |
|
277 |
161 |
$9K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
634 |
407 |
$9K |
| 90678 |
|
33 |
32 |
$9K |
| 86706 |
|
1,650 |
1,555 |
$9K |
| 80299 |
|
2,474 |
1,760 |
$9K |
| 84153 |
|
1,183 |
1,144 |
$9K |
| 80051 |
|
9,890 |
8,321 |
$9K |
| 84425 |
|
687 |
666 |
$9K |
| 87070 |
|
4,246 |
3,941 |
$9K |
| G0008 |
Administration of influenza virus vaccine |
4,156 |
4,076 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,146 |
2,341 |
$8K |
| 98927 |
|
1,804 |
1,650 |
$8K |
| 84403 |
|
549 |
526 |
$8K |
| 0011A |
|
535 |
527 |
$8K |
| 84460 |
|
4,716 |
4,438 |
$8K |
| 81001 |
|
21,111 |
18,613 |
$8K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
245 |
100 |
$8K |
| 99385 |
|
110 |
105 |
$8K |
| 11981 |
|
106 |
100 |
$8K |
| 85651 |
|
7,185 |
6,251 |
$8K |
| 81025 |
|
13,297 |
12,154 |
$8K |
| 83880 |
|
4,960 |
4,361 |
$7K |
| 0071A |
|
196 |
195 |
$7K |
| 84450 |
|
4,786 |
4,485 |
$7K |
| 64483 |
|
73 |
72 |
$7K |
| 90656 |
|
905 |
902 |
$7K |
| 84520 |
|
11,781 |
9,809 |
$7K |
| 86618 |
|
1,495 |
1,429 |
$7K |
| 95913 |
|
65 |
62 |
$7K |
| 88342 |
|
2,092 |
1,939 |
$7K |
| 99348 |
|
216 |
161 |
$6K |
| 80076 |
|
1,593 |
1,471 |
$6K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
543 |
507 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,946 |
2,874 |
$6K |
| 87581 |
|
5,757 |
5,341 |
$6K |
| 90662 |
|
1,808 |
1,758 |
$6K |
| 91200 |
|
109 |
102 |
$6K |
| 86850 |
|
3,641 |
3,291 |
$6K |
| 20551 |
|
132 |
104 |
$5K |
| 70498 |
|
841 |
776 |
$5K |
| 82043 |
|
3,806 |
3,642 |
$5K |
| 86708 |
|
920 |
868 |
$5K |
| 29075 |
|
84 |
69 |
$5K |
| 84100 |
|
3,071 |
2,504 |
$5K |
| 0072A |
|
131 |
131 |
$5K |
| 93229 |
|
606 |
350 |
$5K |
| 95251 |
|
492 |
483 |
$5K |
| 87147 |
|
3,533 |
3,295 |
$5K |
| 73080 |
|
742 |
656 |
$4K |
| 85018 |
|
4,148 |
3,556 |
$4K |
| 87641 |
|
287 |
272 |
$4K |
| 82247 |
|
2,217 |
1,936 |
$4K |
| 76770 |
|
54 |
54 |
$4K |
| 83021 |
|
246 |
241 |
$4K |
| 82784 |
|
1,378 |
957 |
$4K |
| 95819 |
|
25 |
25 |
$4K |
| 88307 |
|
856 |
665 |
$4K |
| 84146 |
|
346 |
330 |
$4K |
| 93280 |
|
535 |
524 |
$4K |
| 96150 |
|
37 |
37 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
184 |
180 |
$4K |
| 87536 |
|
179 |
168 |
$4K |
| 74178 |
|
53 |
49 |
$4K |
| 93798 |
|
80 |
12 |
$4K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
230 |
131 |
$4K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
483 |
463 |
$4K |
| 82248 |
|
2,920 |
2,578 |
$4K |
| 86317 |
|
212 |
105 |
$4K |
| 82570 |
|
1,672 |
1,545 |
$3K |
| 81003 |
|
11,008 |
10,168 |
$3K |
| 84270 |
|
250 |
237 |
$3K |
| 90734 |
|
1,787 |
1,691 |
$3K |
| 77062 |
|
62 |
62 |
$3K |
| 0031A |
|
176 |
175 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,679 |
4,480 |
$3K |
| 83690 |
|
13,607 |
12,026 |
$3K |
| 87640 |
|
299 |
279 |
$3K |
| 87077 |
|
4,184 |
3,843 |
$3K |
| 93926 |
|
119 |
112 |
$3K |
| 97116 |
|
570 |
382 |
$3K |
| 83001 |
|
337 |
313 |
$3K |
| 96156 |
|
64 |
63 |
$3K |
| 73564 |
|
671 |
595 |
$3K |
| 85730 |
|
3,357 |
2,873 |
$3K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
161 |
114 |
$3K |
| 84446 |
|
353 |
337 |
$3K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
149 |
144 |
$3K |
| 84590 |
|
399 |
385 |
$3K |
| 72040 |
|
216 |
199 |
$3K |
| 93225 |
|
68 |
65 |
$3K |
| 84597 |
|
310 |
299 |
$3K |
| 87205 |
|
3,573 |
3,251 |
$3K |
| 83993 |
|
192 |
188 |
$3K |
| 99335 |
|
87 |
67 |
$3K |
| 73140 |
|
330 |
294 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
212 |
188 |
$3K |
| 86431 |
|
1,175 |
1,121 |
$2K |
| 73590 |
|
507 |
425 |
$2K |
| 0124A |
|
253 |
236 |
$2K |
| 92582 |
|
30 |
30 |
$2K |
| 82670 |
|
134 |
123 |
$2K |
| 84075 |
|
1,579 |
1,452 |
$2K |
| 99383 |
|
36 |
36 |
$2K |
| 90716 |
|
1,191 |
1,133 |
$2K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
172 |
167 |
$2K |
| 86160 |
|
463 |
288 |
$2K |
| 93976 |
|
39 |
38 |
$2K |
| 92579 |
|
112 |
110 |
$2K |
| 11720 |
|
346 |
339 |
$2K |
| 82274 |
|
331 |
318 |
$2K |
| 43248 |
|
12 |
12 |
$2K |
| 86376 |
|
319 |
299 |
$2K |
| 94729 |
|
2,251 |
2,157 |
$2K |
| 93295 |
|
151 |
141 |
$2K |
| 72131 |
|
89 |
82 |
$2K |
| 84156 |
|
1,469 |
1,281 |
$2K |
| 94726 |
|
499 |
469 |
$2K |
| 74174 |
|
16 |
15 |
$2K |
| 87209 |
|
144 |
138 |
$2K |
| 0064A |
|
158 |
157 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
448 |
436 |
$2K |
| 84480 |
|
290 |
260 |
$2K |
| G0127 |
Trimming of dystrophic nails, any number |
652 |
630 |
$2K |
| 98926 |
|
518 |
469 |
$2K |
| 84165 |
|
609 |
573 |
$2K |
| 11056 |
|
88 |
86 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16,523 |
13,469 |
$2K |
| G0250 |
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests |
2,285 |
2,230 |
$2K |
| 51705 |
|
29 |
24 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,516 |
7,834 |
$2K |
| 87625 |
|
109 |
102 |
$2K |
| 82040 |
|
1,909 |
1,751 |
$1K |
| 90620 |
|
88 |
72 |
$1K |
| 99397 |
|
168 |
155 |
$1K |
| 93308 |
|
148 |
141 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
962 |
942 |
$1K |
| 99177 |
|
224 |
222 |
$1K |
| 77280 |
|
28 |
24 |
$1K |
| 90649 |
|
808 |
800 |
$1K |
| 82550 |
|
1,278 |
1,089 |
$1K |
| 51798 |
|
2,605 |
2,458 |
$1K |
| 90480 |
|
62 |
58 |
$1K |
| 80164 |
|
394 |
366 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,119 |
9,774 |
$1K |
| 84703 |
|
1,553 |
1,488 |
$1K |
| 87046 |
|
119 |
113 |
$1K |
| 99496 |
|
39 |
39 |
$1K |
| 64405 |
|
12 |
12 |
$1K |
| 99292 |
|
19 |
18 |
$1K |
| 93271 |
|
13 |
13 |
$1K |
| 97035 |
|
286 |
113 |
$1K |
| 88720 |
|
282 |
248 |
$1K |
| 83520 |
|
180 |
173 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,431 |
15,021 |
$1K |
| 74230 |
|
28 |
27 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,269 |
9,921 |
$1K |
| 72170 |
|
134 |
118 |
$1K |
| 92552 |
|
12 |
12 |
$1K |
| 83605 |
|
6,613 |
5,580 |
$1K |
| 81002 |
|
3,455 |
3,164 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,975 |
3,175 |
$1K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
12 |
12 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
96 |
82 |
$1K |
| G0378 |
Hospital observation service, per hour |
6,274 |
3,201 |
$1K |
| 96523 |
|
54 |
53 |
$1K |
| 93351 |
|
25 |
25 |
$1K |
| 88304 |
|
1,357 |
1,121 |
$999.44 |
| 87177 |
|
144 |
138 |
$984.02 |
| 72146 |
|
12 |
12 |
$966.59 |
| 73090 |
|
221 |
180 |
$958.84 |
| 84630 |
|
146 |
139 |
$952.85 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,399 |
9,754 |
$950.50 |
| J3490 |
Unclassified drugs |
2,293 |
1,908 |
$929.92 |
| 76882 |
|
39 |
36 |
$927.25 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
6,808 |
5,768 |
$912.80 |
| 84160 |
|
607 |
571 |
$907.01 |
| 90673 |
|
94 |
94 |
$874.53 |
| 99441 |
|
97 |
96 |
$868.38 |
| 86787 |
|
79 |
77 |
$867.21 |
| 93270 |
|
83 |
50 |
$862.90 |
| 86255 |
|
118 |
106 |
$862.27 |
| 85045 |
|
741 |
700 |
$856.37 |
| 99310 |
Prolong nursin fac eval 15m |
16 |
12 |
$854.27 |
| 93016 |
|
79 |
76 |
$848.20 |
| 96380 |
|
55 |
55 |
$847.00 |
| 85380 |
|
3,142 |
2,903 |
$844.24 |
| 82525 |
|
114 |
106 |
$807.79 |
| 83615 |
|
922 |
775 |
$799.13 |
| 85014 |
|
2,017 |
1,600 |
$794.33 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
148 |
137 |
$792.09 |
| 87040 |
|
3,983 |
2,884 |
$771.61 |
| 96376 |
|
4,748 |
3,176 |
$768.98 |
| 86352 |
|
2,119 |
1,924 |
$761.89 |
| G0009 |
Administration of pneumococcal vaccine |
314 |
304 |
$761.48 |
| 83883 |
|
172 |
159 |
$746.23 |
| 99347 |
|
58 |
44 |
$726.87 |
| 99221 |
|
27 |
26 |
$720.30 |
| 84550 |
|
530 |
503 |
$712.67 |
| 99337 |
|
14 |
12 |
$712.08 |
| 76870 |
|
69 |
66 |
$703.14 |
| 99350 |
Prolong home eval add 15m |
14 |
13 |
$689.32 |
| 97166 |
|
26 |
25 |
$687.84 |
| 84132 |
|
599 |
511 |
$685.77 |
| 82310 |
|
639 |
532 |
$669.92 |
| 94727 |
|
925 |
891 |
$667.99 |
| 87427 |
|
105 |
100 |
$661.20 |
| 17250 |
|
36 |
27 |
$657.80 |
| 87493 |
|
58 |
54 |
$644.00 |
| 90619 |
|
451 |
426 |
$633.88 |
| 87045 |
|
119 |
113 |
$591.97 |
| 82805 |
|
2,011 |
1,683 |
$583.34 |
| 99152 |
|
2,674 |
2,365 |
$567.51 |
| 93018 |
|
79 |
76 |
$563.64 |
| 90681 |
|
2,355 |
2,234 |
$560.90 |
| 73700 |
|
14 |
12 |
$550.57 |
| 84484 |
|
14,252 |
10,964 |
$548.98 |
| 82977 |
|
168 |
161 |
$544.35 |
| 91320 |
|
31 |
27 |
$530.04 |
| 86923 |
|
56 |
49 |
$513.70 |
| 93246 |
|
28 |
28 |
$498.01 |
| 93283 |
|
26 |
26 |
$496.37 |
| 51702 |
|
26 |
25 |
$482.14 |
| 90682 |
|
15 |
14 |
$473.65 |
| 82785 |
|
71 |
64 |
$455.68 |
| D1206 |
Topical application of fluoride varnish |
46 |
46 |
$453.75 |
| 86665 |
|
27 |
26 |
$438.30 |
| 73552 |
|
97 |
82 |
$433.11 |
| 92611 |
|
25 |
25 |
$427.98 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,622 |
4,538 |
$424.61 |
| 82533 |
|
68 |
54 |
$422.64 |
| 83002 |
|
47 |
40 |
$417.51 |
| 93289 |
|
40 |
40 |
$401.24 |
| 99173 |
|
187 |
187 |
$400.18 |
| 88300 |
|
668 |
595 |
$374.26 |
| 85049 |
|
374 |
355 |
$367.76 |
| 86200 |
|
92 |
87 |
$356.79 |
| 86361 |
|
107 |
97 |
$353.33 |
| 11721 |
|
24 |
24 |
$351.83 |
| 74019 |
|
32 |
29 |
$351.04 |
| 99495 |
|
13 |
12 |
$331.01 |
| G0400 |
Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels |
14 |
14 |
$330.86 |
| 93288 |
|
14 |
14 |
$329.11 |
| 72128 |
|
12 |
12 |
$324.46 |
| 99305 |
|
12 |
12 |
$277.56 |
| 00811 |
|
12 |
12 |
$268.44 |
| 92610 |
|
24 |
24 |
$262.22 |
| 97605 |
|
22 |
12 |
$254.09 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
89 |
86 |
$232.72 |
| 80177 |
|
56 |
54 |
$211.04 |
| 84134 |
|
32 |
25 |
$210.50 |
| 92551 |
|
25 |
25 |
$207.50 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
14 |
12 |
$205.31 |
| 93325 |
|
207 |
197 |
$203.71 |
| C1769 |
Guide wire |
3,139 |
2,786 |
$190.88 |
| 82951 |
|
18 |
18 |
$179.18 |
| 86334 |
|
28 |
27 |
$177.74 |
| 86705 |
|
25 |
25 |
$176.55 |
| 82150 |
|
113 |
111 |
$174.67 |
| 86225 |
|
27 |
25 |
$174.61 |
| 87338 |
|
24 |
24 |
$173.95 |
| 90723 |
|
2,105 |
2,021 |
$168.13 |
| 73060 |
|
32 |
25 |
$165.62 |
| 82172 |
|
31 |
29 |
$165.18 |
| 82272 |
|
421 |
395 |
$157.18 |
| 93294 |
|
33 |
33 |
$155.78 |
| 93352 |
|
12 |
12 |
$151.62 |
| 86901 |
|
3,642 |
3,290 |
$150.08 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,954 |
2,418 |
$146.09 |
| 93321 |
|
73 |
71 |
$143.20 |
| 73100 |
|
84 |
75 |
$141.91 |
| 36416 |
|
15,681 |
11,782 |
$141.14 |
| 90744 |
|
200 |
198 |
$138.44 |
| 99153 |
Mod sedat endo service >5yrs |
1,362 |
1,213 |
$135.89 |
| 81000 |
|
467 |
444 |
$131.64 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,028 |
10,443 |
$124.62 |
| 12001 |
|
481 |
461 |
$119.64 |
| 86039 |
|
28 |
28 |
$117.03 |
| 86762 |
|
12 |
12 |
$116.18 |
| 84681 |
|
15 |
12 |
$115.90 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
3,287 |
3,112 |
$112.86 |
| 82962 |
|
2,767 |
2,592 |
$109.75 |
| 86664 |
|
12 |
12 |
$102.27 |
| 82010 |
|
876 |
734 |
$101.02 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
1,195 |
1,014 |
$100.72 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,057 |
1,795 |
$100.30 |
| 96402 |
|
16 |
12 |
$99.33 |
| 74022 |
|
14 |
14 |
$92.58 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
348 |
326 |
$92.38 |
| 86765 |
|
15 |
15 |
$91.69 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
355 |
295 |
$90.89 |
| 86709 |
|
12 |
12 |
$90.08 |
| 71101 |
|
13 |
13 |
$89.59 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
30 |
25 |
$86.44 |
| 93226 |
|
68 |
65 |
$85.94 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,150 |
3,271 |
$85.03 |
| 36600 |
|
27 |
27 |
$84.63 |
| 84295 |
|
50 |
43 |
$80.44 |
| 0003A |
|
13 |
12 |
$80.02 |
| 76937 |
|
2,845 |
2,443 |
$72.69 |
| 84155 |
|
127 |
118 |
$68.10 |
| 90715 |
|
5,975 |
5,649 |
$67.94 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
930 |
811 |
$66.44 |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,735 |
2,620 |
$65.19 |
| 86308 |
|
82 |
78 |
$63.12 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
42 |
33 |
$61.86 |
| 87634 |
|
72 |
70 |
$60.66 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,494 |
5,133 |
$60.15 |
| 87207 |
|
63 |
60 |
$59.90 |
| 87807 |
|
154 |
143 |
$49.75 |
| 12011 |
|
54 |
49 |
$47.84 |
| 82140 |
|
37 |
28 |
$43.71 |
| J7999 |
Compounded drug, not otherwise classified |
980 |
883 |
$43.56 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,223 |
2,548 |
$41.56 |
| 88108 |
|
24 |
24 |
$41.09 |
| 82952 |
|
18 |
18 |
$40.66 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,997 |
1,615 |
$40.18 |
| 82374 |
|
27 |
25 |
$40.14 |
| 0012A |
|
95 |
95 |
$40.01 |
| 82435 |
|
28 |
26 |
$37.77 |
| 86800 |
|
15 |
13 |
$28.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,816 |
2,782 |
$22.06 |
| 88302 |
|
53 |
43 |
$21.24 |
| 98929 |
|
12 |
12 |
$20.22 |
| 83721 |
|
12 |
12 |
$19.34 |
| J2060 |
Injection, lorazepam, 2 mg |
3,000 |
2,483 |
$13.33 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
406 |
361 |
$11.67 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
975 |
798 |
$10.06 |
| J1790 |
Injection, droperidol, up to 5 mg |
284 |
249 |
$4.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
42 |
37 |
$4.44 |
| 90672 |
|
13 |
13 |
$0.13 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
29 |
28 |
$0.02 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
693 |
596 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,617 |
1,226 |
$0.00 |
| 77417 |
|
76 |
37 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
12 |
12 |
$0.00 |
| 90696 |
|
912 |
865 |
$0.00 |
| 90647 |
|
2,473 |
2,361 |
$0.00 |
| 96368 |
|
103 |
67 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
643 |
592 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
283 |
277 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
212 |
190 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,019 |
826 |
$0.00 |
| 90698 |
|
115 |
110 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
604 |
513 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
570 |
555 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
331 |
295 |
$0.00 |
| 36410 |
|
723 |
625 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
208 |
178 |
$0.00 |
| 91306 |
|
65 |
64 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
217 |
137 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
395 |
347 |
$0.00 |
| 91303 |
|
98 |
98 |
$0.00 |
| 88341 |
|
788 |
657 |
$0.00 |
| 91307 |
|
332 |
300 |
$0.00 |
| 94760 |
|
959 |
621 |
$0.00 |
| 90697 |
|
1,108 |
1,032 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
15 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
168 |
161 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
163 |
141 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
258 |
182 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
298 |
286 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
56 |
30 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
29 |
28 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
389 |
352 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
614 |
543 |
$0.00 |
| 77001 |
|
157 |
146 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
44 |
30 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
45 |
41 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
59 |
54 |
$0.00 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
652 |
542 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
14 |
12 |
$0.00 |
| 93320 |
|
14 |
14 |
$0.00 |
| G8992 |
Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting |
15 |
15 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
48 |
48 |
$0.00 |
| 91301 |
|
682 |
668 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
13 |
12 |
$0.00 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
29 |
29 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
25 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
70 |
67 |
$0.00 |
| L3924 |
Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf |
14 |
13 |
$0.00 |
| 94761 |
|
103 |
61 |
$0.00 |
| 90381 |
|
45 |
45 |
$0.00 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
14 |
14 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
112 |
107 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
580 |
361 |
$0.00 |
| 90707 |
|
1,158 |
1,094 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,096 |
1,692 |
$0.00 |
| 90633 |
|
2,806 |
2,663 |
$0.00 |
| 91300 |
|
4,793 |
4,399 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
654 |
582 |
$0.00 |
| 90648 |
|
88 |
87 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,013 |
4,809 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
913 |
886 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,213 |
825 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
23 |
13 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
700 |
598 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
130 |
100 |
$0.00 |
| 90700 |
|
1,216 |
1,134 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
802 |
688 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
140 |
123 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,864 |
851 |
$0.00 |
| 90710 |
|
1,385 |
1,318 |
$0.00 |
| C1776 |
Joint device (implantable) |
27 |
26 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
259 |
237 |
$0.00 |
| 90685 |
|
691 |
683 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
38 |
38 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
592 |
372 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
535 |
512 |
$0.00 |
| 88173 |
|
41 |
36 |
$0.00 |
| 93356 |
|
42 |
40 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
298 |
282 |
$0.00 |
| 76376 |
|
113 |
107 |
$0.00 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
27 |
27 |
$0.00 |
| 91312 |
|
237 |
222 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
130 |
89 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
264 |
223 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
80 |
69 |
$0.00 |
| C1729 |
Catheter, drainage |
287 |
153 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
100 |
89 |
$0.00 |
| 88360 |
|
24 |
24 |
$0.00 |
| 82800 |
|
71 |
54 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
55 |
53 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
16 |
14 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
50 |
24 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
37 |
36 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
28 |
24 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
14 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
14 |
14 |
$0.00 |
| 90713 |
|
27 |
27 |
$0.00 |
| 91308 |
|
16 |
13 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
18 |
18 |
$0.00 |